1. Clinical Developments in Idiopathic Pulmonary Fibrosis: Expert Insights

2. Demographics of IPF in the USa-d

3. Major Goals of Treatment

4. Managing Shortness of Breath

5. Common Comorbidities in IPF

6. Additional Management Considerations

7. The State of IPF Management

8. Pirfenidone: The ASCEND Trial

9. Results

10. Results (cont)

11. Results (cont)

12. Adverse Events

13. Study Conclusions

14. Nintedanib: INPULSIS-1 and INPULSIS-2

15. Results

16. Time to First Acute Exacerbation

17. Adverse Events

18. Study Conclusion

19. Discussion of Potential Implications

20. IPF Clinical Research Network: PANTHER Trial

21. IPF Clinical Research Network: PANTHER Trial (cont)

22. Results

23. Conclusions

24. Abbreviations

25. References

26. References (cont)

27. References (cont)

28. References (cont)